Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Titel:
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Auteur:
Chan, Henry L Y Fung, Scott Seto, Wai Kay Chuang, Wan-Long Chen, Chi-Yi Kim, Hyung Joon Hui, Aric Josun Janssen, Harry L A Chowdhury, Abhijit Tsang, Tak Yin Owen Mehta, Rajiv Gane, Edward Flaherty, John F Massetto, Benedetta Gaggar, Anuj Kitrinos, Kathryn M Lin, Lanjia Subramanian, G Mani McHutchison, John G Lim, Young-Suk Acharya, Subrat K Agarwal, Kosh